Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Preferred Shares (2021 - 2025)

Bioadaptives' Preferred Shares history spans 5 years, with the latest figure at $1.0 for Q3 2025.

  • For Q3 2025, Preferred Shares fell 99.66% year-over-year to $1.0; the TTM value through Sep 2025 reached $1.0, down 99.66%, while the annual FY2024 figure was $7.0, 600.0% up from the prior year.
  • Preferred Shares for Q3 2025 was $1.0 at Bioadaptives, down from $100.0 in the prior quarter.
  • Across five years, Preferred Shares topped out at $335.0 in Q1 2024 and bottomed at $1.0 in Q4 2023.
  • The 5-year median for Preferred Shares is $160.0 (2021), against an average of $137.25.
  • The largest annual shift saw Preferred Shares soared 600.0% in 2024 before it tumbled 99.66% in 2025.
  • A 5-year view of Preferred Shares shows it stood at $160.0 in 2021, then changed by 0.0% to $160.0 in 2022, then plummeted by 99.38% to $1.0 in 2023, then skyrocketed by 600.0% to $7.0 in 2024, then crashed by 85.71% to $1.0 in 2025.
  • Per Business Quant, the three most recent readings for BDPT's Preferred Shares are $1.0 (Q3 2025), $100.0 (Q2 2025), and $7.0 (Q1 2025).